Impact of Lockdown Restrictions on Treatment of Leprosy: A Retrospective Analysis
- PMID: 36226013
- PMCID: PMC9549562
- DOI: 10.4103/idoj.idoj_768_21
Impact of Lockdown Restrictions on Treatment of Leprosy: A Retrospective Analysis
Abstract
Context: Coronavirus disease 2019 (COVID-19) has shown the potential to affect the life of people all over the world either directly or indirectly.
Aim: To assess the impact of lockdown measures on treatment of leprosy among patients who received treatment from a tertiary referral centre.
Settings and design: A retrospective study was conducted at the dermatology department of a tertiary referral centre.
Materials and methods: We did a retrospective analysis of case records of patients with leprosy who received treatment from our tertiary referral centre from 01 March 2020 to 31 May 2021.
Results: During the 15-month period, 59 patients received multi-drug therapy (MDT) for leprosy from our centre. Thirty-two patients (54.2%) were already receiving MDT as on March 2020, and 27 others (45.8%) were diagnosed with leprosy and started on MDT during the period from March 2020 to May 2021. Two patients (3.4%) developed COVID-19 while on MDT. When lockdown measures were implemented, 12 patients (12/59, 20.3%) discontinued treatment, citing conveyance difficulties. Three patients (3/59, 5.1%) were lost to follow-up.
Limitations: Small sample size and reliance on retrospective data from a single centre were the major limitations of the study.
Conclusion: A conscious effort is needed from healthcare professionals and the government to ensure that implementation of national programmes is not adversely affected by the ongoing COVID-19 pandemic.
Keywords: Coronavirus disease-2019; Kerala; leprosy; lockdown measures; regular treatment.
Copyright: © 2022 Indian Dermatology Online Journal.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
An assessment of the reported impact of the COVID-19 pandemic on leprosy services using an online survey of practitioners in leprosy referral centres.Trans R Soc Trop Med Hyg. 2021 Dec 2;115(12):1456-1461. doi: 10.1093/trstmh/trab084. Trans R Soc Trop Med Hyg. 2021. PMID: 34077950 Free PMC article.
-
Integration of leprosy into GHS in India: a follow up study (2006-2007).Lepr Rev. 2010 Dec;81(4):306-17. Lepr Rev. 2010. PMID: 21313976
-
Management of minor burns during the COVID-19 pandemic: A patient-centred approach.Scars Burn Heal. 2021 Jun 17;7:20595131211020566. doi: 10.1177/20595131211020566. eCollection 2021 Jan-Dec. Scars Burn Heal. 2021. PMID: 34211739 Free PMC article.
-
Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.Int J Lepr Other Mycobact Dis. 1992 Sep;60(3):436-44. Int J Lepr Other Mycobact Dis. 1992. PMID: 1474282 Review.
-
Role of contact tracing and prevention strategies in the interruption of leprosy transmission.Lepr Rev. 2014 Mar;85(1):2-17. Lepr Rev. 2014. PMID: 24974438
Cited by
-
Impact of the COVID-19 Pandemic on the Detection of Leprosy in Micro-Regions with a High Risk of Illness in Minas Gerais, Brazil.Infect Dis Rep. 2024 Nov 26;16(6):1098-1107. doi: 10.3390/idr16060089. Infect Dis Rep. 2024. PMID: 39728011 Free PMC article.
References
-
- World Health Organization. Geneva, Switzerland: WHO; 1998. WHO Technical Report Series No. 874. Seventh report. Expert committee on leprosy.
-
- Training Manual for Medical Officers 2019, Chapter 6. Management of leprosy. National Leprosy Eradication Programme. New Delhi:Directorate of Health Services, Ministry of Health and Family Welfare. 2020. [Last accessed on 2020 Mar 11]. Available from:http://nlep.nic.in/training.html .
LinkOut - more resources
Full Text Sources